Anticoagulant Reversal
37:41
DOACs in Renal Dysfunction and Liver Disease
20:59
The Blessing and Curse of Direct Oral Anticoagulants in the Bleeding Patient
1:00:57
Update on Andexanet Alfa for Reversal of FXa Inhibitors: Annexa-I Trial Webinar
11:35
Anticoagulation Reversal Strategies
3:10:39
Antiplatelet, Anticoagulant, Thrombolytic Agents
1:03:18
Making Rounds: Medical Education Documentary Film
32:51
Reversing oral anticoagulants with a focus on Andexanet Alfa
1:05:44